MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1188)	4/8/1999 12:35:00 AM
From: scaram(o)uche	Read Replies (2) of 1826

A Phase II Trial of MGI 114 in Patients with Hormone-Refractory Prostate Cancer General Poster Session: Prostate Cancer Date: "May 17, 1999" Time: 8:00 AM - 12:00 PM Location: Hall C (East Wing)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next